{
    "clinical_study": {
        "@rank": "70347", 
        "arm_group": [
            {
                "arm_group_label": "acetate Ringer's solution", 
                "arm_group_type": "Active Comparator", 
                "description": "Administering acetate Ringer's solution that contains no glucose as an initial infusion A total infusion volume of acetate Ringer's solution is 1500ml"
            }, 
            {
                "arm_group_label": "acetate Ringer's solution with 1% glucose", 
                "arm_group_type": "Active Comparator", 
                "description": "Administering the acetate Ringer's solution that contains 1% glucose as an initial infusion A total infusion volume of the acetate Ringer's solution containing 1% glucose is 1500ml (containing 15g of glucose)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of administering a small dose of\n      glucose on the pregnant women and their neonates during cesarean section.  We investigate\n      the safety and efficacy of use of a glucose-containing solution for the pregnant women and\n      the neonates."
        }, 
        "brief_title": "The Effect of Administering a Small Dose of Glucose During Cesarean Section", 
        "condition": "Cesarean Section", 
        "detailed_description": {
            "textblock": "Rapid infusion of large amount of glucose is associated with fetal hyperglycemia,\n      hyperinsulinemia, and neonatal hypoglycemia. However, the effect of small dose of glucose is\n      unclear.  We conducted a pilot study of small dose of glucose.  We investigated the effect\n      of a glucose-containing fluid on the blood sugar of the umbilical artery.  We found that in\n      the case of no-glucose-containing fluid, there were some cases in which umbilical arterial\n      concentration of glucose was less than 50 mg/dl, which might cause neonatal hypoglycemia.\n      In addition, in the case of 1%-glucose-containing fluid, mean umbilical arterial\n      concentration of glucose was 97 mg/dl.\n\n      The purpose of this study is to investigate the effect of administering a small dose of\n      glucose on the pregnant women and their neonates during cesarean section.  We investigate\n      the safety and efficacy of use of a glucose-containing solution for the pregnant women and\n      the neonates."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing cesarean section who met the criteria of the American Society of\n             Anesthesiologists physical status of 1-2\n\n        Exclusion Criteria:\n\n          -  ASA physical status >=3, Obesity (BMI>35), Height>=175cm, Weight>=80Kg"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706341", 
            "org_study_id": "NCU-573"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "acetate Ringer's solution", 
                    "acetate Ringer's solution with 1% glucose"
                ], 
                "description": "During cesarean section under spinal anesthesia, each acetate Ringer's solution is administered before delivery.", 
                "intervention_name": "administer acetate Ringer's solution", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "acetate Ringer's solution", 
                "intervention_name": "acetate Ringer's solution containing no glucose", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "acetate Ringer's solution with 1% glucose", 
                "intervention_name": "acetate Ringer's solution containing 1% glucose", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "cesarean section", 
            "intravenous fluid", 
            "a glucose-containing solution", 
            "fetal hypoglycemia", 
            "neonatal hypoglycemia"
        ], 
        "lastchanged_date": "October 11, 2012", 
        "location": {
            "contact": {
                "email": "masui@med.nagoya-cu.ac.jp", 
                "last_name": "Yoshihito Fujita, MD. PhD.", 
                "phone": "+81-52-851-5511", 
                "phone_ext": "8281"
            }, 
            "contact_backup": {
                "email": "sayasaya2002@yahoo.co.jp", 
                "last_name": "Saya Yoshizawa, MD.", 
                "phone": "+52-851-5511", 
                "phone_ext": "8281"
            }, 
            "facility": {
                "address": {
                    "city": "Nagoya", 
                    "country": "Japan", 
                    "zip": "467-8601"
                }, 
                "name": "Departiment of Anesthesiology, Nagoya City University Hospital"
            }, 
            "investigator": {
                "last_name": "Saya Yoshizawa, MD.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Administering a Small Dose of Glucose on the Pregnant Women and Their Neonates During Cesarean Section", 
        "other_outcome": {
            "measure": "Evidence of clinical complications (especially, low glucose symptoms)", 
            "safety_issue": "Yes", 
            "time_frame": "Within the first 3 days after cesarean section"
        }, 
        "overall_contact": {
            "email": "masui@med.nagoya-cu.ac.jp", 
            "last_name": "Yoshihito Fujita, MD. PhD.", 
            "phone": "+81-52-851-5511", 
            "phone_ext": "8281"
        }, 
        "overall_contact_backup": {
            "email": "sayasaya2002@yahoo.co.jp", 
            "last_name": "Saya Yoshizawa, MD.", 
            "phone": "+52-851-5511", 
            "phone_ext": "8281"
        }, 
        "overall_official": {
            "affiliation": "Department of Anesthesiology, Nagoya City Universtiy", 
            "last_name": "Yoshihito Fujita, MD. PhD.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The blood glucose concentration in the neonates at one hour of age", 
            "safety_issue": "Yes", 
            "time_frame": "One hour of age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706341"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nagoya City University", 
            "investigator_full_name": "Yoshihito Fujita, MD", 
            "investigator_title": "Associate professor, the department of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The blood glucose concentration in the neonates at two hour of age", 
            "safety_issue": "Yes", 
            "time_frame": "Two hour of age"
        }, 
        "source": "Nagoya City University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nagoya City University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}